Comparison of the effect of oral zinc sulfate on the prevention of chemotherapy-induced oral mucositis

Phase 3

Recruiting

• Conditions: Breast Cancer.; Malignant neoplasm of breast of unspecified site; C50.9

• Registration Number: IRCT20150304021338N2
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 92

Inclusion Criteria

Having a biopsy-confirmed cancer.
Candidate for chemotherapy containing adriamycin and cyclophosphamide
Having a normal serum zinc level
Satisfaction to participate in the study

Exclusion Criteria

Infection of the oral mucosa before the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: Before starting chemotherapy and once every three weeks for up to 12 weeks. Method of measurement: Visual Analog Scale (VAS).;Incidence of oral mucositis. Timepoint: Before starting chemotherapy and once every three weeks for up to 12 weeks. Method of measurement: Observation.;Quality of Life. Timepoint: Before starting chemotherapy and once every three weeks for up to 12 weeks. Method of measurement: Cancer Patients Quality of Life Questionnaire.